Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Printed Publications in Post-Grant Reviews

By John Isacson on August 5, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

GRÜNENTHAL GMBH v. ANTECIP BIOVENTURES II LLC, PGR2019-00026, -00027, 00028 (PTAB, July 28, 2020)

The PTAB issued decisions in a trio of post-grant reviews. One of the defenses put forward by the Patent Owner was that the asserted references did not qualify as printed publications. The analyses by the PTAB is largely the same in each decision, and therefore only PGR2019-00026 will be cited.

Patent Owner contended the Petitioner had not established that the references were publicly available. Petitioner relied upon dates set forth in the references themselves and a declaration from a technical expert who testified on availability of the references. Slip op. at 20. Patent owner contended that the dates in the references are not enough on their own to establish public availability, but did not provide any evidence that contradicted Petitioner’s evidentiary showing. Slip op. at 20-21. Ultimately, the PTAB sided with the Petitioner, and held that that a preponderance of the evidence showed that the references were prior art printed publications. Slip op. at 22.

Photo of John Isacson John Isacson

A registered patent attorney, John has particular experience in strategic counseling and patent portfolio management, infringement litigation, due diligence, inter partes and post-grant reviews, reexaminations, patent interferences, inventorship and ownership disputes, biosimilars, and Hatch-Waxman. He is regularly involved in litigation and U.S. Patent…

A registered patent attorney, John has particular experience in strategic counseling and patent portfolio management, infringement litigation, due diligence, inter partes and post-grant reviews, reexaminations, patent interferences, inventorship and ownership disputes, biosimilars, and Hatch-Waxman. He is regularly involved in litigation and U.S. Patent and Trademark Office proceedings. John also advises on related FDA matters for certain technologies.

Read more about John IsacsonEmailJohn's Linkedin Profile
Show more Show less
  • Posted in:
    Intellectual Property
  • Blog:
    PostGrant-Counsel Blog
  • Organization:
    Troutman Pepper Locke

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo